Anti-Complement C5 Antibody (Vilobelimab)
Catalog No.
F1362
Anti-Complement C5 Antibody (Vilobelimab)
Featured Products
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody. The anaphylatoxin C5a is a pro-inflammatory complement split product that plays a central role in mediating organ dysfunction. Vilobelimab can be used as a C5a inhibitor to inhibit neutrophil activation and chemotaxis, reduce inflammatory signals, etc., and can be used in sepsis, COVID-19 and other related studies.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.88 kDa
Dry ice
2250440-41-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IFX-1, CaCP29, INab308
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01031
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Complement C5
Please avoid freeze-thaw cycles.